Bristol Myers Valuation
| BMYMP Stock | USD 761.00 39.00 4.87% |
At this time, the firm appears to be overvalued. Bristol Myers Squibb shows a prevailing Real Value of $684.39 per share. The current price of the firm is $761.0. Our model approximates the value of Bristol Myers Squibb from analyzing the firm fundamentals such as Revenue of 46.38 B, net income of 7.01 B, and Cash Per Share of 3.72 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bristol Myers' price fluctuation is very steady at this time. Calculation of the real value of Bristol Myers Squibb is based on 3 months time horizon. Increasing Bristol Myers' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Bristol Myers' intrinsic value may or may not be the same as its current market price of 761.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 761.0 | Real 684.39 | Hype 800.0 | Naive 791.95 |
The intrinsic value of Bristol Myers' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bristol Myers' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bristol Myers Squibb helps investors to forecast how Bristol pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bristol Myers more accurately as focusing exclusively on Bristol Myers' fundamentals will not take into account other important factors: Bristol Myers Total Value Analysis
Bristol Myers Squibb is currently expected to have takeover price of 0 with market capitalization of 2.11 T, debt of 39.6 B, and cash on hands of 6.07 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bristol Myers fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 2.11 T | 39.6 B | 6.07 B |
Bristol Myers Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Bristol connotes not a very effective usage of assets in July.Bristol Myers Profitability Analysis
The company reported the revenue of 46.38 B. Net Income was 7.01 B with profit before overhead, payroll, taxes, and interest of 0.About Bristol Myers Valuation
The pink sheet valuation mechanism determines Bristol Myers' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Bristol Myers Squibb based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bristol Myers. We calculate exposure to Bristol Myers's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bristol Myers's related companies.Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.
8 Steps to conduct Bristol Myers' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bristol Myers' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bristol Myers' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bristol Myers' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bristol Myers' revenue streams: Identify Bristol Myers' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bristol Myers' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bristol Myers' growth potential: Evaluate Bristol Myers' management, business model, and growth potential.
- Determine Bristol Myers' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bristol Myers' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Bristol Myers Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bristol Myers does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.6 B | |
| Retained Earnings | 23.8 B | |
| Retained Earnings Total Equity | 23.8 B |
Additional Tools for Bristol Pink Sheet Analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.